GENETHERA INC. (OTCMKTS:GTHR) is up today after announcing a partnership agreement with Cumming Corporation.
GTHR is up as of 11:50. Shares are trading at .092 up .042 for an 84% gain on the day. 1.2 million shares have traded hands already well above its 30-day average daily volume of 265,709. Trading opened at .0557 and hit a high of .12 before settling back.
ITEM 1.01 GENETHERA, INC. AND CUMMING MANAGEMENT GROUP, INC. ENTERED INTO A CONSULTING AGREEMENT
On April 9, 2021 GeneThera Inc. entered into a consulting agreement with Cumming Management Group, Inc. According to the terms on the agreement, Cumming will provide support services related to the construction of GeneThera’s Biosafety Level 3 (BSL-3) laboratory facilities to be used as molecular robotic diagnostic therapeutic and research facilities for SARS-CoV-2 and other zoonotic diseases. Scope of the services and fees are outlined in Exhibit A and B attached to the Consulting Agreement. GeneThera will proceed with Cumming as its sole consulting services provider for the related BSL-3 Lab project.
About GeneThera, Inc.
GeneThera is a biotechnology company developing molecular robotic/AI diagnostics and therapeutics in an effort to control and eradicate zoonotic diseases. GeneThera developed molecular assays for BSE and Mycobacterium Avium Paratuberculosis (MAP). MAP is an infectious organism causing Paratuberculosis in dairy cows that is also linked to Crohn’s Disease in humans. We utilize these technologies to minimize the spread of animal infectious organisms such as SARS-CoV-2 to humans. Management and prevention of zoonotic diseases is crucial to human and animal health on a global scale.
Today’s action is the heaviest in 15 sessions. The rally stalled just above the .1130 area which proved to be a turning point in the stock a few weeks back. If GTHR can hold today’s strong gains and get above .12 again over the next few days it may be enough to get a rally going.